Friedreich Ataxia
What's New
Last Posted: Nov 29, 2024
- Assessment of the Clinical Interactions of GAA Repeat Expansions in FGF14 and FXN.
Brandon J Gerhart, et al. Neurology. Genetics 2024 0 (6) e200210 - End-of-Life Discussions With Patients and Caregivers Affected By Neurogenetic Diseases.
Dorsemans Anne-Claire et al. Neurol Clin Pract 2023 13(6) e200199 - How great a risk do you take? A qualitative study exploring attitudes of individuals with Friedreich ataxia towards gene therapy.
Katherine Lieschke et al. Hum Gene Ther 2023 - Depressive symptoms in Friedreich ataxia.
Nieto Antonieta, et al. International journal of clinical and health psychology : IJCHP 2018 0 (1) 18-26 - Clarification of undiagnosed ataxia using whole-exome sequencing with clinical implications.
Kim Minkyeong, et al. Parkinsonism & related disorders 2020 0 58-64 - Diagnostic Efficacy of Genetic Studies in a Series of Hereditary Cerebellar Ataxias in Eastern Spain.
Baviera-Muñoz Raquel, et al. Neurology. Genetics 2022 0 (6) e200038 - A non-synonymous single nucleotide polymorphism in SIRT6 predicts neurological severity in Friedreich ataxia.
Rodden Layne N, et al. Frontiers in molecular biosciences 2022 0 933788 - Dissecting the epidemiology of a trinucleotide repeat disease - example of FRDA in Finland.
Juvonen Vesa, et al. Human genetics 2002 0 (1) 36-40 - The inherited cerebellar ataxias: an update.
Coarelli Giulia et al. Journal of neurology 2022 - A wearable video-oculography based evaluation of saccades and respective clinical correlates in patients with early onset ataxia.
Summa Susanna et al. Journal of neuroscience methods 2020 Mar 338108697
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: